| scholarly article | Q13442814 |
| P356 | DOI | 10.1165/AJRCMB/6.4.359 |
| P698 | PubMed publication ID | 1312850 |
| P50 | author | Jeffrey A Kern | Q63373813 |
| P2093 | author name string | A. Gazdar | |
| R. A. Robinson | |||
| D. B. Weiner | |||
| L. Torney | |||
| P2860 | cites work | Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 |
| A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
| Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
| Ribonucleic acid isolated by cesium chloride centrifugation | Q29616561 | ||
| Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes | Q34272920 | ||
| Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. | Q41721035 | ||
| A point mutation in the neu oncogene mimics ligand induction of receptor aggregation | Q44611984 | ||
| Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics. | Q45946068 | ||
| Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor | Q48369441 | ||
| The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen | Q52827123 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proto-oncogene | Q30555 |
| P304 | page(s) | 359-363 | |
| P577 | publication date | 1992-04-01 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines | |
| P478 | volume | 6 |
| Q34073788 | Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation |
| Q34124421 | C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. |
| Q27002075 | Human epidermal growth factor receptor signaling in acute lung injury |
| Q41524948 | Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody. |
| Q44120928 | Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. |
| Q52169558 | Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. |
| Q34695953 | Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury. |
| Q34679340 | Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary results |
| Q35252008 | Overexpression of the p185erB-2 tyrosine kinase growth factor receptor: control or chaos |
| Q26865861 | Pulmonary epithelial barrier function: some new players and mechanisms |
| Q40616262 | Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. |
| Q36292265 | The role of transforming growth factor alpha production and ErbB-2 overexpression in induction of tumorigenicity of lung epithelial cells |
| Q74800297 | [CYFRA 21.1 cytosol levels in lung adenocarcinomas. Correlation with other clinico-biological parameters] |
Search more.